10150- MPC-14 THE COMPARISON BETWEEN HISTOLOGICAL DIAGNOSIS, GENOME-WIDE DNA METHYLATION PROFILING AND INTEGRATED DIAGNOSIS FOR PEDIATRIC LOW-GRADE GLIOMA

Abstract INTRODUCTION Genome-wide DNA methylation profiling is performed for pediatric low-grade glioma (pLGG) with diagnostic challenge. We compared histological diagnosis, DNA methylation profiling and integrated diagnosis for pLGG. METHODS We analyzed histology, molecular findings, DNA methylation profiling and integrated diagnosis of pLGG that were registered to the central diagnosis of Japan Children’s Cancer Group from March 2018 to June 2024 and underwent genome-wide DNA methylation profiling. RESULTS Fifty-eight cases were enrolled. Thirty-seven cases (64%) had calibrated scores of 0.84 or higher (match), and 21 cases (36%) had the scores below 0.84 (no match). Definitive diagnoses based on integrated diagnoses were achieved in 22 cases (59%) among the match cases, in 6 cases among the no match cases and in total 28 cases (48%). Tumor types of the 28 cases with definitive diagnoses were pilocytic astrocytoma (PA) in 16 cases, diffuse low-grade glioma, MAPK pathway-altered in 2 cases, subependymal giant cell astrocytoma in 2 cases, dysembryoplastic neuroepithelial tumour in 2 cases, and others in 6 cases. All 6 cases with definitive diagnoses among the no match cases were PA. Discrepancies between histological diagnosis and methylation class were observed in total 34 cases (match 17 cases, no match 17 cases). Among the 34 cases, definitive diagnoses were achieved in 8 cases (match 6 cases, no match 2 cases) and all the diagnoses supported the histological diagnoses. Twenty-one cases of the 34 cases were histologically diagnosed with unspecific tumor types like low-grade glioma or classified to MC Control tissue in DNA methylation profiling. DISCUSSION/CONCLUSION Genome-wide DNA methylation profiling was useful for pLGG matched to specific methylation class. Sixteen percents of the match cases showed discrepancy between histological diagnoses and methylation class, but supported histological diagnoses as definitive diagnoses, indicating the importance of integrated diagnosis.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology Advances
Published
2024-11-29
DOI
https://doi.org/10.1093/noajnl/vdae173.055
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

10150- MPC-14 THE COMPARISON BETWEEN HISTOLOGICAL DIAGNOSIS, GENOME-WIDE DNA METHYLATION PROFILING AND INTEGRATED DIAGNOSIS FOR PEDIATRIC LOW-GRADE GLIOMA

Takako Yoshioka, Yuko Matsushita, Junko Hirato, Akira Miyahira et al.
Neuro-Oncology Advances
Glioma Diagnosis and Treatment
article

10150- MPC-14 THE COMPARISON BETWEEN HISTOLOGICAL DIAGNOSIS, GENOME-WIDE DNA METHYLATION PROFILING AND INTEGRATED DIAGNOSIS FOR PEDIATRIC LOW-GRADE GLIOMA

Takako Yoshioka, Yuko Matsushita, Junko Hirato, Akira Miyahira, Yoshihiro Otani, Kaishi Satomi, Yoshiko Nakano, Joji Ishida, Kohei Fukuoka, Koichi Ichimura, Hibiya Yuko, Yohei Inoue, Kai Yamasaki, Shota Tanaka
article en

Abstract

Abstract INTRODUCTION Genome-wide DNA methylation profiling is performed for pediatric low-grade glioma (pLGG) with diagnostic challenge. We compared histological diagnosis, DNA methylation profiling and integrated diagnosis for pLGG. METHODS We analyzed histology, molecular findings, DNA methylation profiling and integrated diagnosis of pLGG that were registered to the central diagnosis of Japan Children’s Cancer Group from March 2018 to June 2024 and underwent genome-wide DNA methylation profiling. RESULTS Fifty-eight cases were enrolled. Thirty-seven cases (64%) had calibrated scores of 0.84 or higher (match), and 21 cases (36%) had the scores below 0.84 (no match). Definitive diagnoses based on integrated diagnoses were achieved in 22 cases (59%) among the match cases, in 6 cases among the no match cases and in total 28 cases (48%). Tumor types of the 28 cases with definitive diagnoses were pilocytic astrocytoma (PA) in 16 cases, diffuse low-grade glioma, MAPK pathway-altered in 2 cases, subependymal giant cell astrocytoma in 2 cases, dysembryoplastic neuroepithelial tumour in 2 cases, and others in 6 cases. All 6 cases with definitive diagnoses among the no match cases were PA. Discrepancies between histological diagnosis and methylation class were observed in total 34 cases (match 17 cases, no match 17 cases). Among the 34 cases, definitive diagnoses were achieved in 8 cases (match 6 cases, no match 2 cases) and all the diagnoses supported the histological diagnoses. Twenty-one cases of the 34 cases were histologically diagnosed with unspecific tumor types like low-grade glioma or classified to MC Control tissue in DNA methylation profiling. DISCUSSION/CONCLUSION Genome-wide DNA methylation profiling was useful for pLGG matched to specific methylation class. Sixteen percents of the match cases showed discrepancy between histological diagnoses and methylation class, but supported histological diagnoses as definitive diagnoses, indicating the importance of integrated diagnosis.

Neuro-Oncology AdvancesVol. 6(Supplement_4)
Okayama University (JP), Kyorin University (JP), Juntendo University (JP), Saitama Children's Medical Center (JP), Osaka City General Hospital (JP), University of Tokyo Hospital (JP), Gunma Museum of Natural History (JP), National Center For Child Health and Development (JP), Neurological Surgery (US)
Good health and well-being
Openalex Percentile: Top 62%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.